Adverum Biotechnologies Statistics
Total Valuation
ADVM has a market cap or net worth of $91.07 million. The enterprise value is $153.84 million.
Important Dates
The last earnings date was Wednesday, November 12, 2025, after market close.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ADVM has 22.08 million shares outstanding. The number of shares has increased by 26.37% in one year.
| Current Share Class | 22.08M |
| Shares Outstanding | 22.08M |
| Shares Change (YoY) | +26.37% |
| Shares Change (QoQ) | +11.79% |
| Owned by Insiders (%) | 11.36% |
| Owned by Institutions (%) | 32.10% |
| Float | 12.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.65
| Current Ratio | 0.65 |
| Quick Ratio | 0.58 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -417.79% and return on invested capital (ROIC) is -94.11%.
| Return on Equity (ROE) | -417.79% |
| Return on Assets (ROA) | -76.90% |
| Return on Invested Capital (ROIC) | -94.11% |
| Return on Capital Employed (ROCE) | -682.47% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.19M |
| Employee Count | 155 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -36.05% in the last 52 weeks. The beta is 0.87, so ADVM's price volatility has been lower than the market average.
| Beta (5Y) | 0.87 |
| 52-Week Price Change | -36.05% |
| 50-Day Moving Average | 4.40 |
| 200-Day Moving Average | 3.47 |
| Relative Strength Index (RSI) | 43.61 |
| Average Volume (20 Days) | 376,749 |
Short Selling Information
The latest short interest is 811,403, so 3.68% of the outstanding shares have been sold short.
| Short Interest | 811,403 |
| Short Previous Month | 982,682 |
| Short % of Shares Out | 3.68% |
| Short % of Float | 6.45% |
| Short Ratio (days to cover) | 0.93 |
Income Statement
| Revenue | n/a |
| Gross Profit | -77.12M |
| Operating Income | -188.72M |
| Pretax Income | -184.79M |
| Net Income | -184.79M |
| EBITDA | -186.22M |
| EBIT | -188.72M |
| Earnings Per Share (EPS) | -$8.56 |
Full Income StatementBalance Sheet
The company has $26.06 million in cash and $88.94 million in debt, giving a net cash position of -$62.88 million or -$2.85 per share.
| Cash & Cash Equivalents | 26.06M |
| Total Debt | 88.94M |
| Net Cash | -62.88M |
| Net Cash Per Share | -$2.85 |
| Equity (Book Value) | -55.65M |
| Book Value Per Share | -2.53 |
| Working Capital | -15.84M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$137.90 million and capital expenditures -$543,000, giving a free cash flow of -$138.45 million.
| Operating Cash Flow | -137.90M |
| Capital Expenditures | -543,000 |
| Free Cash Flow | -138.45M |
| FCF Per Share | -$6.27 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ADVM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -26.37% |
| Shareholder Yield | -26.37% |
| Earnings Yield | -203.16% |
| FCF Yield | -152.21% |
Analyst Forecast
The average price target for ADVM is $11.60, which is 181.21% higher than the current price. The consensus rating is "Buy".
| Price Target | $11.60 |
| Price Target Difference | 181.21% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 110.01% |
| EPS Growth Forecast (5Y) | -5.81% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 21, 2024. It was a reverse split with a ratio of 1:10.
| Last Split Date | Mar 21, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
ADVM has an Altman Z-Score of -31.86 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -31.86 |
| Piotroski F-Score | 1 |
